Literature DB >> 18620110

Steady as a ROC: the Resuscitation Outcomes Consortium.

Peter Morley.   

Abstract

Mesh：

Year:  2008        PMID： 18620110     DOI： 10.1016/j.resuscitation.2008.06.007

Source DB:  PubMed          Journal:  Resuscitation        ISSN： 0300-9572            Impact factor:   5.262


× No keyword cloud information.
  5 in total

1.  Making thawed universal donor plasma available rapidly for massively bleeding trauma patients: experience from the Pragmatic, Randomized Optimal Platelets and Plasma Ratios (PROPPR) trial.

Authors:  Deborah J Novak; Yu Bai; Rhonda K Cooke; Marisa B Marques; Magali J Fontaine; Jerome L Gottschall; Patricia M Carey; Richard M Scanlan; Eberhard W Fiebig; Ira A Shulman; Janice M Nelson; Sherri Flax; Veda Duncan; Jennifer A Daniel-Johnson; Jeannie L Callum; John B Holcomb; Erin E Fox; Sarah Baraniuk; Barbara C Tilley; Martin A Schreiber; Kenji Inaba; Sandro Rizoli; Jeanette M Podbielski; Bryan A Cotton; John R Hess
Journal:  Transfusion       Date:  2015-03-30       Impact factor: 3.157

2.  Etomidate as an induction agent in septic patients: red flags or false alarms?

Authors:  Erik B Kulstad; Ejaaz A Kalimullah; Karis L Tekwani; D Mark Courtney
Journal:  West J Emerg Med       Date:  2010-05

3.  [German resuscitation registry : science and resuscitation research].

Authors:  J-T Gräsner; S Seewald; A Bohn; M Fischer; M Messelken; T Jantzen; J Wnent
Journal:  Anaesthesist       Date:  2014-06       Impact factor: 1.041

4.  Improved survival in the real world with revised cardiopulmonary resuscitation guidelines: doing better out of hospital but not out of the woods yet.

Authors:  Subha Varahan; Ruchir Sehra; Sanjiv M Narayan
Journal:  Heart Rhythm       Date:  2010-05-19       Impact factor: 6.343

5.  Developing templates for uniform data documentation and reporting in critical care using a modified nominal group technique.

Authors:  Hans Morten Lossius; Andreas J Krüger; Kjetil Gorseth Ringdal; Stephen J M Sollid; David J Lockey
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-11-26       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.